The Latest Analyst Ratings for Karuna Therapeutics
Portfolio Pulse from Benzinga Insights
Analysts have provided bullish ratings for Karuna Therapeutics (NASDAQ:KRTX) in the last quarter, with an average price target of $281.25, indicating an upside from the current price of $185.38. The average price target has increased by 5.5% from the previous average of $266.60.
August 04, 2023 | 9:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Karuna Therapeutics has received bullish ratings from analysts, with an average price target of $281.25, indicating potential upside.
The bullish ratings and increased price target indicate analysts' positive outlook on Karuna Therapeutics, which could potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100